About AntiCoagAF
Updated information about DOACs and their use in non-valvular atrial fibrillation management (Feb 2022), and for iOS 15. This application is for medical practitioners who need to quickly review which anticoagulant...
Updated information about DOACs and their use in non-valvular atrial fibrillation management (Feb 2022), and for iOS 15.
This application is for medical practitioners who need to quickly review which anticoagulant (including the direct oral anticoagulants (DOACs)) to use to prevent stroke in patients with non-valvular atrial fibrillation (NVAF).
It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban.
Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a DOAC, starting or switching between anticoagulants, edoxban information, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on DOACs, reversing anticoagulation in the event of intracerebral haemorrhage, a Cookcroft-Gault creatinine clearance calculator and peri-operative management information.
Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.
Feb 2, 2022
Version 1.3
Updated by Prof Bruce Campbell, University of Melbourne, for 2022 use. Added information about new DOAC reversal agents. Helpful for management of stroke, peri-operative care and other decisions involving DOAC use.
Previous Versions
Here you can find the changelog of AntiCoagAF since it was posted on our website on 2016-10-13 20:11:20.
The latest version is 1.3 and it was updated on 2024-04-22 17:24:49. See below the changes in each version.
AntiCoagAF version 1.3
Updated At: 2022-02-02
Changes: Feb 2, 2022 Version 1.3
Updated by Prof Bruce Campbell, University of Melbourne, for 2022 use. Added information about new DOAC reversal agents. Helpful for management of stroke, peri-operative care and other decisions involving DOAC use.
AntiCoagAF version 1.2.0
Updated At: 2020-12-06
Changes: 6 Dec 2020 Version 1.2.0
Minor bug fixes only.
AntiCoagAF version 1.2.0
Updated At: 2020-12-06
Changes: Dec 6, 2020 Version 1.2.0
Minor bug fixes only.
AntiCoagAF version 1.1.1
Updated At: 2020-06-14
Changes: Jun 14, 2020 Version 1.1.1
Updated for iOS 13 in SwiftUI.
AntiCoagAF version 1.1.1
Updated At: 2020-06-14
Changes: 14 Jun 2020 Version 1.1.1
Updated for iOS 13 in SwiftUI.
AntiCoagAF version 1.0.7
Updated At: 2020-01-21
Changes: Jan 21, 2020 Version 1.0.7
Sharing is simpler and uses all available local options. Updated source code to Swift.
AntiCoagAF version 1.0.3
Updated At: 2013-11-26
AntiCoagAF version 1.1.1
Updated At: 1970-01-01
Changes: 2020年6月14日 Version 1.1.1
Updated for iOS 13 in SwiftUI.
Disclaimer
Official App Store Link
We do not host AntiCoagAF on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Apple and passed their terms and conditions to be listed there. We recommend caution when installing it.
The App Store link for AntiCoagAF is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
